¼¼°èÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀå
Intravenous Needles
»óǰÄÚµå : 1763280
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 93 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,225,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,675,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀº 2030³â±îÁö 42¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.3%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Å×Ç÷кÐÁÖħÀº CAGR 6.9%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ºÅ×Àθ®½º°­ ºÐÁÖħ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 4,880¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀº 2024³â¿¡ 7¾ï 4,880¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 10¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 10.0%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.5%¿Í 5.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è Á¤¸Æ ÁÖ»ç ¹Ù´Ã ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¿ä¾à

Á¤¸ÆÁÖ»ç ¹Ù´ÃÀÌ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Á¤¸ÆÁÖ»ç(IV) ¹Ù´ÃÀº ´Ù¾çÇÑ Ä¡·á¿¡ ÇÊ¿äÇÑ Ç÷°ü ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¢±ÙÀ» Á¦°øÇÔÀ¸·Î½á Çö´ë ÀÇ·á ÇàÀ§¿¡¼­ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ±×·¸´Ù¸é Á¤¸Æ ÁÖ»ç ¹Ù´ÃÀÌ ¿À´Ã³¯ ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡? Á¤¸Æ ÁÖ»ç¹Ù´ÃÀº ȯÀÚÀÇ Ç÷·ù¿¡ Á÷Á¢ÀûÀ¸·Î ¼öºÐ, ¾à¹°, ¿µ¾çºÐÀ» °ø±ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼öÇÑ Áß°ø Æ©ºêÀÔ´Ï´Ù. ÀÀ±ÞÀÇ·á, ¼ö¼ú ¹× Àå±â ȯÀÚ Ä¡·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ÀÇ·áÁøÀÌ ½Å¼ÓÇϰí È¿°úÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Á¤¸Æ ÁÖ»ç ¹Ù´ÃÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀº º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ȯÀڵ鿡°Ô ÇʼöÀûÀÎ ÅøÀÌ µÇ¾ú½À´Ï´Ù.

ÀÇ·á ¼ö¿ä Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ Á¤¸ÆÁÖ»ç ¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­¿Í ´ç´¢º´, ¾Ï µî Á¤±âÀûÀÎ Á¤¸ÆÁÖ»ç Ä¡·á°¡ ÇÊ¿äÇÑ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾ÈÀüÇϰí È¿°úÀûÀÎ Á¤¸ÆÁÖ»ç Á¢±Ù¿¡ ´ëÇÑ Çʿ伺ÀÌ °¡Àå Å©°Ô ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í°ú °°Àº °Ç°­ À§±â¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ´ëÀÀÀ¸·Î ÀÎÇØ ¹é½Å Á¢Á¾ ¹× Ä¡·á Ȱµ¿À» ÃËÁøÇϱâ À§ÇÑ Á¤¸Æ ÁÖ»ç ¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí È¿À²ÀûÀÎ Ä¡·á¸¦ º¸ÀåÇϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó Á¤¸Æ ÁÖ»ç¹Ù´Ã ½ÃÀåÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº Á¤¸Æ ÁÖ»ç ¹Ù´ÃÀÇ Ç°ÁúÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀº Áß¿äÇÑ ÀÇ·á±â±âÀÇ ¾ÈÀü¼º, À¯È¿¼º ¹× »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â Å« ±â¼úÀû Áøº¸¸¦ ¸ñ°ÝÇß½À´Ï´Ù. ±×·¸´Ù¸é ÀÌ·¯ÇÑ ¹ßÀüÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â ÁÖ¿ä ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡? °¡Àå ¿µÇâ·Â ÀÖ´Â ¹ßÀü Áß Çϳª´Â ¹Ù´Ã¿¡ Âñ¸± À§ÇèÀ» ÃÖ¼ÒÈ­Çϵµ·Ï ¼³°èµÈ ¾ÈÀü ¼³°è Á¤¸Æ ÁÖ»ç¹Ù´ÃÀÇ µµÀÔÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁÖ»ç¹Ù´ÃÀº »ç¿ë ÈÄ ¹Ù´ÃÀ» ¼ö³³Çϰųª ½Ç¼ö·Î Âñ¸®Áö ¾Êµµ·Ï º¸È£ÇÏ´Â ¸ÞÄ¿´ÏÁòÀ» °®Ãß°í ÀÖ´Â °æ¿ì°¡ ¸¹¾Æ ÀÇ·áÁø°ú ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ô¿´½À´Ï´Ù. ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ±â¼ú Çõ½ÅÀº ƯÁ¤ ¿ëµµ¿¡ ¸Â°Ô Ư¼öÇÏ°Ô µðÀÚÀÎµÈ ¸µ°Å ¹Ù´ÃÀÇ °³¹ßÀÔ´Ï´Ù. Á¦Á¶¾÷üµéÀº ´Ù¾çÇÑ °ÔÀÌÁö, ±æÀÌ, ±×¸®°í »ðÀԽà ¾ÈÁ¤¼º°ú Á¦¾î·ÂÀ» Çâ»ó½ÃŰ´Â ³¯°³Çü µðÀÚÀÎ µîÀÇ Æ¯Â¡À» °®Ãá Á¤¸ÆÁÖ»ç ¹Ù´ÃÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÇ·áÁøÀº ȯÀÚ ¹× ½Ã¼ú¿¡ µû¶ó ÃÖÀûÀÇ ¹Ù´ÃÀ» ¼±ÅÃÇÒ ¼ö ÀÖ°Ô µÇ¾î Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í ÇÕº´Áõ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Á¤¸Æ ÁÖ»ç¹Ù´Ã µðÀÚÀÎÀÇ ¸ÂÃãÈ­ ¹× ¼º´É Çâ»ó Ãß¼¼´Â ÀÌ ½ÃÀå ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Á¤¸ÆÁÖ»ç ½Ã½ºÅÛ¿¡¼­ ½º¸¶Æ® ±â¼úÀÇ ÅëÇÕµµ ÀÌ ½ÃÀåÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ½Ä ÁÖÀÔ ÆßÇÁ ¹× ½Ç½Ã°£ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº ±â´ÉÀ» ÅëÇØ ÀÇ·á Àü¹®°¡´Â ¾à¹° Åõ¿© ¹× ȯÀÚ ¾ÈÀüÀ» ´õ Àß °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Á¤È®ÇÑ Åõ¾àÀ» °¡´ÉÇÏ°Ô Çϰí ÀÇ·áÁø¿¡°Ô ÀáÀçÀûÀÎ ÇÕº´ÁõÀ» °æ°íÇÒ ¼ö ÀÖÀ¸¸ç, Á¤¸Æ³» Ä¡·áÀÇ Àü¹ÝÀûÀÎ È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­ µðÁöÅÐ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±â¼úÀûÀ¸·Î Áøº¸µÈ Á¤¸Æ ÁÖ»ç¹Ù´Ã ¹× °ü·Ã ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Á¤¸ÆÁÖ»ç ¹Ù´ÃÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ½ÃÀå µ¿ÇâÀº ¹«¾ùÀΰ¡?

ÀÇ·á Á¾»çÀÚÀÇ ¿ä±¸¿Í ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ» ¹Ý¿µÇÏ¿© ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Á¤¸Æ ÁÖ»ç ¹Ù´ÃÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ¸î °¡Áö Áß¿äÇÑ ½ÃÀå µ¿Çâ¿¡ ±âÀÎÇÕ´Ï´Ù. °¡Àå µÎµå·¯Áø µ¿Çâ Áß Çϳª´Â ȯÀÚ ¾ÈÀü°ú °¨¿° °ü¸®¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÇ·á ½Ã¼³¿¡¼­´Â º´¿ø³» °¨¿° ¹× ÁÖ»çħ ¼Õ»óÀ» ¹æÁöÇϱâ À§ÇØ º¸´Ù ¾ö°ÝÇÑ ÇÁ·ÎÅäÄÝÀ» µµÀÔÇϰí ÀÖÀ¸¸ç, ¾ÈÀü¼ºÀ» °í·ÁÇÑ Á¤¸Æ ÁÖ»ç¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð¿¡¼­´Â Á¤¸Æ³» Ä¡·á¿¡ µû¸¥ À§ÇèÀ» ÁÙÀÌ´Â ÀåºñÀÇ »ç¿ëÀ» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÐ¾ß ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Á¤¸ÆÁÖ»ç ¹Ù´ÃÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â ÀçÅÃÄ¡·á ¹× ¿Ü·¡ ȯÀÚ ¼­ºñ½º¿¡ ´ëÇÑ °­Á¶°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ ºÎ»ó°ú ȯÀÚÀÇ ÀçÅà Áø·á·ÎÀÇ Àüȯ¿¡ µû¶ó ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î Á¤¸ÆÁÖ»ç ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚ°¡ Åõ¾à ¹× °£º´ÀÎÀÌ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÈ Á¤¸ÆÁÖ»ç ¹Ù´ÃÀº ȯÀÚµéÀÌ ÀüÅëÀûÀÎ ÀÓ»ó ÇöÀå ÀÌ¿ÜÀÇ Àå¼Ò¿¡¼­ Ä¡·á¸¦ ¹Þ±â¸¦ ¿øÇÔ¿¡ µû¶ó ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó Á¦Á¶¾÷üµéÀº ´Ù¾çÇÑ ¿ëµµ¸¦ À§ÇÑ º¸´Ù ÀûÀÀ·Â ÀÖ´Â Á¤¸ÆÁÖ»ç ¹Ù´Ã ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

E-Commerce¿Í ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å Áõ°¡´Â Á¤¸Æ ÁÖ»ç ¹Ù´Ã ½ÃÀå¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿Â¶óÀÎ ±¸¸ÅÀÇ Æí¸®ÇÔÀ¸·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿Í ¼ÒºñÀÚ´Â ´õ ´Ù¾çÇÑ ¹Ù´Ã Á¦Ç°¿¡ Á¢±ÙÇϰí, ¸®ºä¸¦ Àаí, °¡°ÝÀ» ºñ±³ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±¸¸Å ÇൿÀÇ º¯È­·Î ÀÎÇØ ´õ ¸¹Àº °³ÀεéÀÌ Àü¹®ÀûÀÌ°í °íǰÁúÀÇ Á¤¸ÆÁÖ»ç ¹Ù´Ã Á¦Ç°À» ã°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐÈ­µÈ »óȲÀº ºê·£µå°¡ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô µµ´ÞÇÏ°í °íÀ¯ ÇÑ Á¦Ç°À» È«º¸ ÇÒ ¼öÀÖ°ÔÇÏ¿© Á¤¸Æ ÁÖ»ç ¹Ù´Ã¿¡ ´ëÇÑ °ü½ÉÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼¼°èÀÇ Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀå ¼ºÀåÀº ¾ÈÀüÇϰí È¿À²ÀûÀÎ ÁÖÀÔ ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹Ù´Ã ±â¼úÀÇ ¹ßÀü, ȯÀÚ Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ÀÇ·á »ê¾÷ÀÇ ±Þ¼ÓÇÑ È®ÀåÀ¸·Î, ´õ ¸¹Àº »ç¶÷µéÀÌ Åõ¾à°ú ¼ö¾× ÁÖÀÔÀ» À§ÇÑ È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ°í Çõ½ÅÀûÀÎ Á¤¸Æ ÁÖ»ç ¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶ÇÇÑ Á¤¸Æ ÁÖ»ç¹Ù´ÃÀÇ µðÀÚÀΰú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼úÀÇ ¹ßÀüµµ Áß¿äÇÑ ¼ºÀå ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¼ÒÀç, Á¦Á¶ °øÁ¤ ¹× ¾ÈÀü ¸ÞÄ¿´ÏÁòÀÇ Çõ½ÅÀ¸·Î Á¦Á¶¾÷ü´Â ÀÇ·áÁø°ú ȯÀÚÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇÏ´Â °íǰÁú ¹Ù´ÃÀ» »ý»êÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °¢ ±â¾÷ÀÌ ÀÌ·¯ÇÑ ¹ßÀüÀ» Ȱ¿ëÇÏ¿© Á¦Ç° Á¦°øÀ» °³¼±ÇÏ°í ½ÃÀå ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó Çõ½ÅÀûÀÎ Á¤¸ÆÁÖ»ç ¹Ù´Ã ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ Àú·ÅÇÑ °¡°Ý´ëÀÇ °í¼º´É Á¤¸ÆÁÖ»ç¹Ù´Ã Á¦Ç°À» ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ÀÌ ±â¼úÀº ´õ ¸¹Àº ÀÇ·á ÇöÀå¿¡¼­ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¼¼°è Á¤¸ÆÁÖ»ç¹Ù´Ã ½ÃÀåÀº ÇコÄÉ¾î ºÐ¾ßÀÇ ±ÔÁ¦ Áؼö¿Í ǰÁú Ç¥ÁØ¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼öÇý¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀÌ ÀÇ·á¿ëǰÀÇ Ç°Áú°ú ¾ÈÀü¼ºÀ» ¿ì¼±½ÃÇÔ¿¡ µû¶ó ³ôÀº Á¦Á¶ ±âÁØÀ» ÃæÁ·ÇÏ´Â Á¤¸ÆÁÖ»ç¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ÀÚ»ç Á¦Ç°ÀÌ ¾÷°è ±ÔÁ¤À» ÁؼöÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹Ù´Ã ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü, ¾ÈÀüÇϰí È¿À²ÀûÀÎ Á¤¸ÆÁÖ»ç ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ȯÀÚ Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ ¼¼°è Á¤¸ÆÁÖ»ç ¹Ù´Ã ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å, ½ÃÀå ¼ö¿ä, ¼ÒºñÀÚ ¼±È£µµÀÇ ÁøÈ­´Â ¿ªµ¿ÀûÀ¸·Î ¾ôÇô ½ÃÀåÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí, ±â¾÷¿¡°Ô Á¦Ç° Á¦°ø °­È­, ¼º´É ÃÖÀûÈ­, ¸ÅÃâ Áõ´ë¸¦ À§ÇÑ »õ·Î¿î ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ±â¾÷ÀÌ Àü¹ÝÀûÀÎ ÇコÄɾî Àü·«ÀÇ ÀÏȯÀ¸·Î È¿°úÀûÀÎ Á¤¸Æ ÁÖ»ç¹Ù´Ã ¼Ö·ç¼ÇÀ» Áö¼ÓÀûÀ¸·Î ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ Á¦Ç°µéÀº °æÀï¿¡¼­ ¼º°øÇϱâ À§ÇÑ ÇʼöÀûÀÎ ÅøÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

À¯Çü(Å×Ç÷РÁÖ»çħ, ½ºÅ×Àθ®½º°­ ÁÖ»çħ, ±âŸ À¯Çü), ¿ëµµ(º´¿ø, Áø·á¼Ò, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Intravenous Needles Market to Reach US$4.2 Billion by 2030

The global market for Intravenous Needles estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Teflon Dispensing Needles, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Stainless Steel Dispensing Needles segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$748.8 Million While China is Forecast to Grow at 10.0% CAGR

The Intravenous Needles market in the U.S. is estimated at US$748.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Intravenous Needles Market - Key Trends & Growth Drivers Summarized

Why Are Intravenous Needles Essential for Modern Healthcare?

Intravenous (IV) needles have become a critical component of contemporary medical practice, providing essential access to the vascular system for a variety of treatments. But what exactly makes intravenous needles so vital in today’s healthcare landscape? IV needles are specialized hollow tubes used to deliver fluids, medications, and nutrients directly into a patient’s bloodstream. They play a crucial role in emergency medicine, surgery, and long-term patient care, enabling healthcare providers to administer treatments quickly and effectively. The precision and reliability of intravenous needles make them indispensable tools in hospitals, clinics, and outpatient settings.

The demand for intravenous needles has surged due to increasing healthcare needs and the rising prevalence of chronic diseases. As populations age and the incidence of conditions requiring regular IV therapy, such as diabetes and cancer, increases, the need for safe and effective intravenous access has become paramount. Additionally, the global response to health crises, such as the COVID-19 pandemic, has further amplified the demand for intravenous needles to facilitate vaccination and treatment efforts. As healthcare providers strive to improve patient outcomes and ensure efficient treatments, the intravenous needles market continues to expand.

How Are Technological Advancements Elevating the Quality of Intravenous Needles?

The intravenous needles market has witnessed significant technological advancements that have improved the safety, efficacy, and usability of these essential medical devices. But what are the key innovations driving these developments? One of the most impactful advancements is the introduction of safety-engineered IV needles designed to minimize the risk of needlestick injuries. These needles often feature mechanisms that retract the needle after use or shield it to prevent accidental pricks, enhancing safety for healthcare workers and patients alike. As awareness of safety concerns grows, the demand for these innovative needles is expected to rise.

Another critical innovation is the development of specialized IV needle designs tailored for specific applications. Manufacturers are increasingly offering IV needles with various gauges, lengths, and features, such as winged designs for better stability and control during insertion. These advancements allow healthcare providers to select the most suitable needle for each patient and procedure, improving comfort and reducing the risk of complications. The trend towards customization and enhanced performance in intravenous needle designs is likely to drive growth in this segment of the market.

The integration of smart technology in intravenous needle systems is also shaping the future of this market. Features such as electronic infusion pumps and real-time monitoring systems provide healthcare professionals with greater control over medication delivery and patient safety. These technologies allow for precise dosage administration and can alert medical staff to potential complications, enhancing the overall efficacy of intravenous therapies. As healthcare increasingly adopts digital solutions, the demand for technologically advanced IV needles and related systems is expected to rise.

What Market Trends Are Driving the Adoption of Intravenous Needles Across Various Sectors?

Several key market trends are shaping the adoption of intravenous needles across various sectors, reflecting the evolving needs of healthcare providers and advancements in medical technology. One of the most prominent trends is the increasing demand for patient safety and infection control. As healthcare facilities implement stricter protocols to prevent hospital-acquired infections and needlestick injuries, the demand for safety-engineered intravenous needles is rising. Hospitals and clinics are prioritizing the use of devices that mitigate risks associated with intravenous therapies, driving growth in this segment of the market.

Another key trend driving the adoption of intravenous needles is the growing emphasis on home healthcare and outpatient services. With the rise of telemedicine and a shift towards providing care in patients’ homes, the demand for portable and user-friendly intravenous systems is increasing. Intravenous needles designed for self-administration or easy use by caregivers are becoming more popular as patients seek to manage their treatments outside of traditional clinical settings. This trend encourages manufacturers to develop more adaptable IV needle solutions that cater to a diverse range of applications.

The rise of e-commerce and direct-to-consumer sales is also influencing the intravenous needles market. The convenience of online purchasing allows healthcare providers and consumers to access a wider range of needle products, read reviews, and compare prices. This shift in purchasing behavior is driving growth in the market, as more individuals seek out specialized and high-quality intravenous needle products for both professional and personal use. The digital landscape enables brands to reach a wider audience and promote their unique offerings, further driving interest in intravenous needles.

What Factors Are Driving the Growth of the Global Intravenous Needles Market?

The growth in the global intravenous needles market is driven by several factors, including the increasing demand for safe and efficient intravenous therapies, advancements in needle technology, and the rising focus on patient care. One of the primary growth drivers is the rapid expansion of the healthcare industry, where more individuals are seeking effective solutions for medication administration and fluid delivery. As healthcare providers strive to enhance patient outcomes, the demand for reliable and innovative intravenous needles is expected to rise.

Another key growth driver is the ongoing advancement of technology that enhances the design and safety of intravenous needles. Innovations in materials, manufacturing processes, and safety mechanisms are enabling manufacturers to produce high-quality needles that meet the evolving needs of healthcare providers and patients. As organizations seek to leverage these advancements to improve their product offerings and meet market demands, the demand for innovative intravenous needle solutions is anticipated to grow. Additionally, the increasing availability of affordable and high-performance intravenous needle products is making this technology more accessible to a broader range of healthcare settings.

The global intravenous needles market is also benefiting from the rising emphasis on regulatory compliance and quality standards in healthcare. As consumers prioritize quality and safety in their medical supplies, the demand for intravenous needles that meet high manufacturing standards is increasing. Manufacturers are investing in research and development to ensure that their products comply with industry regulations and provide reliable results, driving growth in the market.

With ongoing advancements in needle technology, the increasing demand for safe and efficient intravenous therapies, and the rising focus on patient care, the global intravenous needles market is poised for sustained growth. The dynamic interplay of technological innovation, market demand, and evolving consumer preferences is set to shape the future of the market, offering businesses new opportunities to enhance their product offerings, optimize performance, and drive revenue growth. As companies continue to prioritize effective intravenous needle solutions as part of their overall healthcare strategies, these products will remain essential tools for achieving success in the competitive medical supply landscape.

SCOPE OF STUDY:

The report analyzes the Intravenous Needles market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Teflon Dispensing Needles, Stainless Steel Dispensing Needles, Other Types); Application (Hospitals, Clinics, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â